Content overview: “How a Tiny Protein Called p11 Amplifies Signals from Receptors Targeted by Many Medicines”. A small protein called p11 is emerging as a key amplifier of cellular signals, according to new research from Karolinska Institutet published in Science Advances. The study shows that p11 interacts with numerous receptors that are already targeted by widely used drugs, suggesting its influence extends far beyond what scientists previously understood. This discovery could explain why some medicines work well in certain patients but not others, and it opens the door to more precise treatments.
By binding to these receptors, p11 appears to boost the signals they send inside cells. Many common medications—including those for pain, inflammation, and depression—act on these same receptors. If p11 levels vary between individuals or tissues, it might affect how strongly a drug works. This listing links straight to the original page, where the content is available in full.